Dataset: Evaluation of Known Roles of ARHGAP32, RGNEF (ARHGEF28), and TDP-43 in Neurodegenerative Disease found in PubMed Literature as of August 5, 2026 - PathMap Experiment #000097

Interactive Data Viewer: Read, View, and Print from Day 1 Use our fully interactive viewer to view, read, and print this research data right from Day 1: https://pathmap.org/viewer.php?id=97 Artificial General Intelligence LLC Claim Evaluated: Evaluation of Known Roles of ARHGAP32, RGNEF (ARHGEF28), and TDP-43 in Neurodegenerative Disease found in PubMed Literature as of August 5, 2026 This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine. 🔍 Novel & Overlooked Insights TDP-43 and FUS share a convergent role in R-loop resolution, a process that is also critical for spinal muscular atrophy (SMA) pathogenesis. RGNEF (Arhgef28) provides a distinct neuroprotective mechanism, with genetic ablation studies confirming its protective role against viral infection. The PX-RICS isoform of ARHGAP32 is uniquely targeted to inhibitory synapses via its N-terminal gephyrin-binding region, which is structurally resolved to overlap with receptor-binding sites. TDP-43 dysfunction causes the skipping of a KCNQ2 pore-encoding exon, resulting in a nonfunctional protein that accumulates in the endoplasmic reticulum and induces intrinsic hyperexcitability. The failure of nuclear pore complex (NPC) integrity is a redox-sensitive trigger for TDP-43 aggregation, establishing a reciprocal regulatory loop between nuclear transport and protein homeostasis. Transcriptional induction of diverse LOAD risk genes in microglia is suppressed by the N-terminal SH2 domain of INPP5D, which regulates RIPK1 kinase activation. The formation of skein-like TDP-43 inclusions is specifically driven by BAG3- and HSP70-guided co-aggregation with actin-binding proteins like filamin. Skeletal muscle-derived miR-126a-5p acts as a transcellular signal that regulates axonal local synthesis of TDP-43, thereby maintaining neuromuscular junction (NMJ) integrity. TDP-43 is not merely an aggregator; it functions as a "transcriptome guardian" whose nuclear loss triggers specific cryptic exon inclusions that directly contribute to synaptic dysfunction. The C-terminal "Molecular Zipper" hypothesis suggests that the physiological dimeric state of TDP-43 is essential for preventing the exposure of aggregation-prone domains. RGNEF (ARHGEF28) is a recognized risk locus for LATE-NC, demonstrating genetic linkages between ALS-related proteins and age-related proteinopathy. ARHGAP32 (PX-RICS) is specifically targeted to inhibitory synapses, highlighting that synaptic degeneration in neurodegenerative disease is spatially and functionally distinct from motor neuron death. Caspase-4 cleavage of TDP-43 represents a primate-specific mechanism facilitating cytoplasmic mislocalization, providing a model for therapeutic inhibition. Small-molecule targeting of the TDP-43 conserved region (CR) can bypass splicing toxicity, offering a potential mechanism-specific treatment strategy. RNA G-quadruplexes act as scaffolds for TDP-43, where failure in maintaining their unfolded state facilitates transformation into pathological aggregates. Co-pathologies, such as ADNC+LATE-NC, often show synergistic effects on cognitive decline, challenging the "one-protein, one-disease" paradigm. PX-RICS is exclusively targeted to inhibitory synapses via gephyrin, identifying a discrete isoform-specific role in neural circuit homeostasis. RGNEF serves a dual function in signaling and bone metabolism, with deficiency promoting bone mass through inhibited osteolysis. TDP-43 pathology exhibits distinct transcriptional signatures, including immune activation and unique vulnerabilities, dependent on morphological subtype (types α, β, A, and B). Cryptic splicing in genes like STMN2 and UNC13A serves as a direct driver of neuronal dysfunction, rather than a mere secondary marker of TDP-43 loss. The cGAS-STING axis is a drug-targetable mediator of neuroinflammation in TDP-43 proteinopathies, with inhibition rescuing lysosomal and phagocytic function. PML nuclear bodies exhibit progressive depletion in sporadic ALS motor neurons, potentially reflecting a exhaustion of cellular defense mechanisms. The "Molecular Zipper" hypothesis identifies NTD-mediated homodimerization as a critical structural checkpoint preventing the transition to pathogenic TDP-43 monomers. WDR49-expressing astrocytes appear to mount a compensatory secretory response, and the loss of this capacity may lower the threshold for ALS pathogenesis. 🧪 Extracted Custom Datapoints 📊 Suggested Experiments Assess the effect of Arhgap32 isoform expression levels on TDP-43 nuclear-cytoplasmic distribution in iPSC-derived motor neurons. Investigate whether RGNEF (Arhgef28) overexpression mitigates TDP-43-induced cryptic splicing in neuronal models. Assess if ARHGAP32 knockdown exacerbates synapse loss in a TDP-43-depleted hiPSC neuron model. Investigate the interaction between RGNEF (ARHGEF28) and TDP-43 in the context of stress granule assembly. Validate the neuroprotective efficacy of XL20 across different ARHGEF28-mutant ALS cell lines. Assess if RGNEF depletion alters TDP-43 nucleocytoplasmic shuttling in iPSC-derived motor neurons under oxidative stress. Perform co-immunoprecipitation between PX-RICS and TDP-43 in cortical neurons to identify potential direct complex formation. 📊 Suggested Studies Perform a comparative spatial transcriptomic analysis of inhibitory synapse markers in ALS models harboring different TDP-43 mutations. Evaluate the prevalence of ARHGAP32 gephyrin-binding domain variants in cohorts of sporadic ALS patients. Longitudinal cohort study correlating RGNEF variants with TDP-43 pathology spread. Multi-omics mapping of the ARHGAP32-synaptic protein interactome in ALS patient-derived neural organoids. Longitudinal transcriptomic profiling of patients stratified by RGNEF and TDP-43 status to assess disease progression. Proteomic screen to evaluate if WDR49-expressing astrocytes modulate the aggregation of TDP-43 or RGNEF mutants. 📊 Swansons Literature Based Discovery Candidates {"Discovered Hypothesis (A to C)":"RGNEF-mediated stabilization of the cytoskeleton might offset the inhibitory synaptic circuit destabilization caused by TDP-43-induced KCNQ2 mis-splicing.","Literature A (Origin)":"RGNEF (ARHGEF28) functions as a host factor\/protective agent in cellular defense (Source 42302780).","Literature C (Target)":"KCNQ2 mis-splicing in ALS models leads to neuronal hyperexcitability (Source 41174170).","The Intersecting Bridge B":"Rho-GEF protein regulation of cytoskeletal organization\/microtubule stability.","Biological Rationale":"Since RGNEF is a Rho-GEF and KCNQ2 dysfunction relates to intrinsic excitability control linked to axonal integrity, the GEF-mediated regulation of local actin\/tubulin dynamics could serve to stabilize excitable membranes in the presence of proteinopathy."} ARHGAP32-mediated synaptic anchoring of inhibitory neurotransmitter receptors may be disrupted by the loss of TDP-43-dependent RNA splicing of synaptic structural genes, leading to the excitatory-inhibitory (E/I) imbalance observed in ALS. ARHGAP32/PX-RICS inhibitory synapse anchoring (ID: 42479840) TDP-43-driven synaptic gene splicing dysfunction (ID: 42234776) Loss of synaptic structural integrity and E/I imbalance TDP-43 maintains the expression of genes critical for synaptic function; its loss results in the downregulation of these synaptic proteins, which likely creates a fragile architectural environment that impairs the anchoring function of ARHGAP32/PX-RICS. {"Discovered Hypothesis (A to C)":"RGNEF-mediated RhoA activation regulates the stability of gephyrin-linked PX-RICS complexes at inhibitory synapses.","Literature A (Origin)":"RGNEF (ARHGEF28) activates RhoA\/Rac1 pathways in bone metabolism (ID: 41571890).","Literature C (Target)":"PX-RICS is anchored by gephyrin to inhibitory synapses, essential for E\/I balance (ID: 42479840).","The Intersecting Bridge B":"RhoA\/Rho-GTPase signaling modules.","Biological Rationale":"PX-RICS is known to contain RhoGAP domains and function at inhibitory synapses; linking the RhoA-GEF (RGNEF) activity to PX-RICS\/gephyrin dynamics suggests a regulatory role of cytoskeleton-dependent synaptic anchoring."} 📊 Contradictions Between Evidences There is no direct contradiction; evidence shows that while TDP-43 and STAU1 abundance are linked to impaired autophagy, the modulation of these pathways provides varying therapeutic results depending on the genetic background (e.g., C9orf72 vs SOD1 models). Conflicting roles reported for CSF1R-positive microglia in AD versus ALS, where regional distribution of these cells does not linearly correlate with presynaptic marker preservation in all neurodegenerative subtypes (ID: 42399983). There is a minor discrepancy regarding whether TDP-43 cytoplasmic aggregates directly cause polysome sequestration (ID: 41554103 argues RACK1/ASC1 role in autophagy rather than polysome sequestration) or if they directly impede global translation (ID: 41845971). 📊 Repurposed Solutions The use of HDAC6 inhibitors (like EKZ-438) and GSK3 inhibitors (like CHIR99021) shows potential as a therapeutic approach to restore TDP-43 proteostasis by modulating either autophagic clearance or caspase-mediated truncation. Carboplatin and Dehydrocostus lactone (DHE) are identified as potential therapeutics targeting NF-κB and NRF2 pathways in reactive astrocytes to mitigate TDP-43-induced neurotoxicity (ID: 42134762, ID: 42458512). The use of IRE1 activators or cGAS inhibitors as therapeutic candidates for TDP-43 proteinopathy (IDs: 42341041, 41809005) represent repurposed interventions from stress response and immune regulation domains. Tags Attractor Table Extracted Keywords & Entities DNA-Binding Proteins, _gates_from_dna-binding_proteins, RNA Splicing, _gates_to_rna_splicing, _gates_from_rna_splicing, Neuronal Plasticity, _gates_to_neuronal_plasticity, Synaptic Transmission, _gates_to_synaptic_transmission, Neuronal Dysfunction, _gates_to_neuronal_dysfunction Run Your Own Analysis PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.